Pictured: Lee Krug
Cancer Guide
By Andrea Peirce, BA, Writer/Editor  |  Friday, October 11, 2013

Memorial Sloan Kettering is recognized worldwide for its treatment of pleural and peritoneal mesothelioma.

Pictured: Daniel Thorek & Jan Grimm
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Wednesday, September 25, 2013

A new imaging approach being investigated by Memorial Sloan Kettering researchers could provide better information about a tumor’s molecular activity, allowing for a more accurate diagnosis.

Pictured: Denis Chi
Ask the Expert
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, September 5, 2013

In this “Ask the Expert” feature, gynecologic surgeon Dennis Chi discusses why screening for ovarian cancer is not as widespread as it is for certain other cancers.

Pictured: Micropapillary Morphology
In the Lab
By Esther Napolitano, BS, Science Writer/Editor  |  Friday, August 9, 2013

A Memorial Sloan Kettering study shows that an abnormal cell pattern found in the tumor tissue of some lung cancer patients may help to predict which tumors are more likely to recur after surgery.

Pictured: Luciano Martelotto, Catherine Cowell & Jorge Reis-Filho
Profile
By Julie Grisham, MS, Science Writer/Editor  |  Monday, August 5, 2013

Jorge Reis-Filho studies the genetic alterations that drive the malignant behavior of cells in rare types of breast cancer.

Cancer Guide
By Andrea Peirce, BA, Writer/Editor  |  Monday, June 24, 2013

Our Pituitary Tumor Center provides comprehensive, world-class care to people with noncancerous tumors of the pituitary gland.

Pictured: Low-dose chest CT scan
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Monday, June 17, 2013

Memorial Sloan Kettering now offers low-dose CT screening for certain smokers at high risk for lung cancer.

Pictured: Andrew Vickers
Finding
By Allyson Collins, MS, Science Writer/Editor  |  Wednesday, April 17, 2013

A study led by Memorial Sloan Kettering investigators indicates nearly half of all prostate cancer deaths by age 75 occur in a small group of men with high PSA levels at age 45.

Pictured: Marc Ladanyi & Gregory Riely
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Wednesday, April 3, 2013

A new guideline has established standards for testing lung cancer tumors for genetic abnormalities, giving more patients a chance to benefit from targeted therapies.

Pictured: Peter Scardino
Q&A
By Esther Napolitano, BS, Science Writer/Editor  |  Thursday, March 14, 2013

Dr. Scardino discusses strategies for how physicians and patients can make the best use of PSA testing and prostate cancer treatment.

Pictured: Major Trends in Modern Cancer Research Seminar
Video
By Julie Grisham, MS, Science Writer/Editor  |  Friday, March 1, 2013

At the seventh annual seminar for high school students and teachers, investigators discuss how cutting-edge biomedical research may ultimately contribute to better treatments for cancer patients.

Pictured: CancerSmart Lecture
Video
By Jim Stallard, MA, Writer/Editor  |  Tuesday, February 5, 2013

In a recent discussion as part of Memorial Sloan Kettering’s CancerSmart lecture series, bladder cancer experts spoke about symptoms, risk factors, and the latest treatment options available.

Pictured: David Klimstra
Q&A
By Memorial Sloan Kettering  |  Thursday, July 26, 2012

Dr. Klimstra, Acting Chair of the Department of Pathology since 2011, discusses the pathologist’s critical role on a patient’s care team.

Center News

Stay Informed

Get the latest information about cancer care and research every month.